PI-LAB-2025-045
Tirzepatide (Compounded), Independent Lab Report
Tirzepatide (Compounded) 30mg · BioRegen Research
Independent testing verdict Pass
This product matched its label.
Identity confirmed and measured purity of 98.2% met the stated ≥99.5% claim. Content measured 99.1% of label.
- Identity verified
- Yes
- Measured purity
- 98.2%
- Content accuracy
- 99.1%
- Test recency
- Current cycle
Mass spectrometry confirmed the labelled compound
Label claimed ≥99.5%
29.74mg measured against 30mg claimed
Published 13 months ago
Specimen PI-LAB-2025-045 Tested by Redpoint Laboratories 17 samples tested from this company Purity & Testing score 99/100
Full laboratory evidence Findings table, methodology, chain of custody and the original report
Findings
| Metric | Label claim | Measured | Assessment |
|---|---|---|---|
| Purity (HPLC) | ≥ 99.5% | 98.2% | Within analytical tolerance |
| Identity (MS) | Tirzepatide (Compounded) | Confirmed | Matches label |
| Content | 30 mg | 29.74 mg | Within 5% of label |
Methodology & chain of custody
HPLC-UV purity, ESI-MS identity, and Karl Fischer water content.
The sample was purchased anonymously through standard retail checkout and shipped to an unaffiliated address, then logged, photographed, and forwarded under chain-of-custody documentation to Redpoint Laboratories. See our full testing methodology.
- Lot / batch
- R8904-25
- Purchased
- Analysed
- Published
- Laboratory
- Redpoint Laboratories
- Test type
- Content verification
Original laboratory report: PI-LAB-2025-045-report.pdf